Dose Selection & Optimization Vendors
Compare partners for dose selection and optimization: quantitative justification of dose levels, regimens and adjustments for development and labeling.
Related workflows
CRO / Research Services Provider · +2 more types
Products: ClinQuick
“Study designs linking PK and PD endpoints provide essential data to make robust dose level decisions for later phase studies.”Source: celerion.com
Also offers: First-in-Human (Phase I) Clinical Pharmacology Support, Clinical Trial Bioanalytical & Biomarker Testing, +2 more
Software / Technology Platform · +4 more types
Products: GastroPlus, MonolixSuite +9 more
“For first-in-human studies, the next phase of development, pediatric dose selection, or for commercialization and labeling support, Simulations Plus uses a model-informed approach…”Source: simulations-plus.com
Also offers: Model-Informed Drug Development (MIDD), PBPK Modeling, +3 more
CRO / Research Services Provider · +2 more types
Products: InStat, CoAuthor
“Selection of dose escalation and dose optimization design”Source: veristat.com
Also offers: Biostatistics & Statistical Programming, Full-Service Clinical Trial Execution (CRO Services), +3 more
CRO / Research Services Provider · +1 more type
“We support dose escalation studies to identify the maximum tolerated dose and establish safe therapeutic ranges. Our team uses stepwise escalation models and PK/PD data to guide…”Source: althian.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Marketing Authorization & Lifecycle Submission Support, +3 more
Service Provider · +2 more types
Products: D.AI.M.I.
“First-in-human dose justification and Phase 2/3 trial simulations”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +6 more
CRO / Research Services Provider · +3 more types
Products: Acceleration Platform
“Dosing strategy: using ADME studies, we determine the appropriate starting dose for humans.”Source: altasciences.com
Also offers: Toxicology Studies, First-in-Human (Phase I) Clinical Pharmacology Support, +2 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“When you need additional support in defining the optimal dose for latter phase trials, we can help through greatly improving the probability of success.”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
Compare listed vendors
What this covers: Quantitative evaluation and justification of candidate dose levels, regimens, and adjustments for clinical development or labeling.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Altasciences | CRO / Research Services Provider | Exposure-Response Modeling, Bioavailability & Bioequivalence Studies | “Dosing strategy: using ADME studies, we determine the appropriate starting dose for humans.”altasciences.com · reviewed Oct 21, 2026 |
| Althian Clinical Research | CRO / Research Services Provider | Bioavailability & Bioequivalence Studies | “We support dose escalation studies to identify the maximum tolerated dose and establish safe therapeutic ranges. Our team uses stepwise escalation models and…”althian.com · reviewed Oct 20, 2026 |
| Celerion | CRO / Research Services Provider | Exposure-Response Modeling, Bioavailability & Bioequivalence Studies | “Study designs linking PK and PD endpoints provide essential data to make robust dose level decisions for later phase studies.”celerion.com · reviewed Oct 12, 2026 |
| IQVIA | CRO / Research Services Provider | — | “When you need additional support in defining the optimal dose for latter phase trials, we can help through greatly improving the probability of success.”iqvia.com · reviewed Oct 15, 2026 |
| ProductLife Group | Service Provider | Exposure-Response Modeling | “First-in-human dose justification and Phase 2/3 trial simulations”plglifesciences.com · reviewed Oct 26, 2026 |
| Simulations Plus | Software / Technology Platform | Exposure-Response Modeling, Bioavailability & Bioequivalence Studies | “For first-in-human studies, the next phase of development, pediatric dose selection, or for commercialization and labeling support, Simulations Plus uses a…”simulations-plus.com · reviewed Oct 26, 2026 |
| Veristat | CRO / Research Services Provider | — | “Selection of dose escalation and dose optimization design”veristat.com · reviewed Oct 26, 2026 |